Drug Stores

(WAG) Walgreen and AmerisourceBergen Get Green Light for Deal

The largest retail pharmacy chain in the U.S., Walgreen Co. (WAG) and Alliance Boots continue to make steady progress to boost their global presence in the prescription drug purchasing space. The regulatory approval for the companies’...

12Aug2013 | | Comments Off on (WAG) Walgreen and AmerisourceBergen Get Green Light for Deal | Continued

(WAG) Walgreens Reaches New 52-Week High

Shares of Walgreen Co. (WAG) touched a new 52-week high of $50.50 on Wednesday, May 15, 2013 following strong annual results of Alliance Boots GmbH. Walgreens has a 45% equity ownership stake in the European pharmacy-led, health and...

23May2013 | | Comments Off on (WAG) Walgreens Reaches New 52-Week High | Continued

(WAG) Still Neutral on Walgreens

On Apr 17, we reaffirmed our long-term Neutral recommendation on Walgreen Co. (WAG) following the mixed second-quarter fiscal 2013 results. While the last quarter results reflect a definite improvement over the past few quarters, the...

2May2013 | | Comments Off on (WAG) Still Neutral on Walgreens | Continued

(RAD) Rite Aid Hits 52-Week High

Following better-than-expected fourth-quarter fiscal 2013 results and an impressive fiscal 2014 outlook, shares of Rite Aid Corp. (RAD) attained a new 52-week high of $2.33 on Friday, Apr 12, before closing at $2.31. This Zacks Rank...

21Apr2013 | | Comments Off on (RAD) Rite Aid Hits 52-Week High | Continued

(WAG) Walgreens Earnings Beat Forecasts – Shares Up

Walgreen Co. (WAG) reported net earnings of $756 million or 79 cents per share in the second quarter of fiscal 2013, higher than the year-ago net earnings of $683 million or 78 cents per share.

However, after adjusting for certain...

28Mar2013 | | Comments Off on (WAG) Walgreens Earnings Beat Forecasts – Shares Up | Continued

(WAG) Walgreens Earnings Preview

Walgreen Co. (WAG) is slated to release its first quarter 2013 earnings results on Friday, December 21, 2012, before the market opens. The Zacks Consensus Estimate currently stands at 67 cents per share for the quarter. This represents...

23Dec2012 | | Comments Off on (WAG) Walgreens Earnings Preview | Continued

(CVS) CVS Caremark Corporation Provides Impressive FY13 View

CVS Caremark Corporation (CVS), one of the largest domestic integrated pharmacy services providers, recently updated its fiscal 2013 outlook and highlighted its growth framework, while reiterating its earlier guidance for the current...

16Dec2012 | | Comments Off on (CVS) CVS Caremark Corporation Provides Impressive FY13 View | Continued

(CVS) CVS Caremark Reports Mixed Third Quarter

CVS Caremark (CVS) reported third quarter 2012 earnings per share (EPS) of 79 cents, up 21.5% year over year. However, after excluding the impact of certain acquisition related expenses from both the periods, the adjusted EPS in the...

20Nov2012 | | Comments Off on (CVS) CVS Caremark Reports Mixed Third Quarter | Continued

(WAG) Walgreen Installs Health Records Solution

In an effort to provide greater flexibility to health care customers, Walgreen (WAG) recently started installing WellHealth EHR, the electronic health record (EHR) solution from Greenway Medical Technologies, Inc....

28Aug2012 | | Comments Off on (WAG) Walgreen Installs Health Records Solution | Continued

(CVS) CVS Caremark Corporation Shares Remain at Neutral

We have reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $47.00.

CVS Caremark’s second quarter adjusted earnings per share (EPS) increased 14.0% year over year to 81cents, beating...

21Aug2012 | | Comments Off on (CVS) CVS Caremark Corporation Shares Remain at Neutral | Continued

(OCR) Omnicare Long-term Care Facility Operator Reports Mixed Second Quarter

Omnicare Inc. (OCR), a provider of drugs to long-term care facilities and nursing homes, reported second quarter 2012 adjusted (excluding one-time expenses) earnings per share of 83 cents, beating the Zacks Consensus Estimate of 79...

29Jul2012 | | Comments Off on (OCR) Omnicare Long-term Care Facility Operator Reports Mixed Second Quarter | Continued

(CVS) Management Churn at CVS Caremark

CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit Management (PBM) business,...

4Apr2012 | | Comments Off on (CVS) Management Churn at CVS Caremark | Continued

(MHS) Medco Healh Analyst Reiterates Shares at Neutral

Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00.

During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks Consensus Estimate of...

22Mar2012 | | Comments Off on (MHS) Medco Healh Analyst Reiterates Shares at Neutral | Continued

(WAG) Walgreen Inks Deal with AARP

Leading drugstore chain Walgreen (WAG) recently entered into a three-year contract with a nonprofit organization AARP, to deliver retail drugstore program benefits to its members belonging to the 50-plus age group. Although both the...

7Mar2012 | | Comments Off on (WAG) Walgreen Inks Deal with AARP | Continued

(CVS) CVS Caremark Remains Neutral

Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00.

CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate...

2Mar2012 | | Comments Off on (CVS) CVS Caremark Remains Neutral | Continued

(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims

Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain Medicare Part D prescription...

13Jan2012 | | 0 comments | Continued

(WAG) Walgreens 2012 First Quarter Earnings Scorecard

Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period.

Previous Quarter...

9Jan2012 | | 0 comments | Continued

(WAG) Walgreen Plans to Offset Express Scripts Loss

Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract, which has just lapsed....

3Jan2012 | | 0 comments | Continued

(CVS) CVS Caremark Corporation to Attend Healthcare Conference

The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will...

30Dec2011 | | 0 comments | Continued

(CVS) CVS Caremark Launches New Pharmacy Advisor Program

CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness.

The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent...

14Nov2011 | | 0 comments | Continued

(MHS) Medco Analyst Maintains Shares at Neutral

Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $56.00.

During the third quarter of fiscal 2011, Medco reported adjusted EPS of $1.07, beating the Zacks Consensus Estimate by 2...

12Nov2011 | | 0 comments | Continued

(CVS) CVS Caremark Posts a Strong Quarter

CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks Consensus Estimate of 67...

6Nov2011 | | 0 comments | Continued

(CVS) Greek Turmoil Dominates Headlines

We have a slew of economic and earnings reports on the docket today, but the Greek turmoil will likely continue to dominate the headlines. On the economic front, we got better-than-expected weekly Jobless Claims numbers, raising hopes for a favorable showing from Friday’s non-farm payroll report.

We...

6Nov2011 | | 0 comments | Continued

(MHS) Medco Health Solutions and United Drug Terminate Joint Venture

Following the termination of the pan-European joint venture between Medco Health Solutions (MHS) and Germany-based Celesio AG, Dublin-based United Drug Plc recently decided to exit from its UK homecare partnership with Medco.

As...

20Oct2011 | | 0 comments | Continued

(WAG) Walgreen Posts Encouraging Quarter

Walgreen (WAG) reported adjusted earnings of 57 cents per share in the fourth quarter of fiscal 2011, beating the Zacks Consensus Estimate of 55 cents and were 38.3% higher than the year-ago quarter.

Results for the quarter...

7Oct2011 | | 0 comments | Continued

(WAG) Walgreen Unveils Flu Impact Report

Walgreen Co. (WAG), the largest drugstore chain in the US, recently came up with findings from the first of a two-part Walgreens Flu Impact Report series. The study reveals the impact of flu and related illness on people’s life.

According...

24Sep2011 | | 0 comments | Continued

(WAG) Walgreen in Elite League

Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 Information Week 500. The company added another feather in its cap when it became the top-ranked company in...

20Sep2011 | | 0 comments | Continued

(WAG) Walgreen Ranked as Technology Innovator

Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became the top-ranked company in...

15Sep2011 | | 0 comments | Continued

(WAG) Walgreen Joins U.S. Cardiac Program

Walgreen (WAG), the US Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) have teamed up in a campaign called Million Hearts...

14Sep2011 | | 0 comments | Continued

(CVS) CVS Caremark Analyst Maintains Shares at Neutral

Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00.

CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate...

11Sep2011 | | 0 comments | Continued